Literature DB >> 6298008

Mitochondrial NADH dehydrogenase-catalyzed oxygen radical production by adriamycin, and the relative inactivity of 5-iminodaunorubicin.

K J Davies, J H Doroshow, P Hochstein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6298008     DOI: 10.1016/0014-5793(83)80153-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


× No keyword cloud information.
  21 in total

1.  Exercise stimulates beneficial adaptations to diminish doxorubicin-induced cellular toxicity.

Authors:  Ashley J Smuder
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-08-28       Impact factor: 3.619

2.  Oxidative and non-oxidative mechanisms in the inactivation of cardiac mitochondrial electron transport chain components by doxorubicin.

Authors:  O Marcillat; Y Zhang; K J Davies
Journal:  Biochem J       Date:  1989-04-01       Impact factor: 3.857

3.  Mitochondria contain a proteolytic system which can recognize and degrade oxidatively-denatured proteins.

Authors:  O Marcillat; Y Zhang; S W Lin; K J Davies
Journal:  Biochem J       Date:  1988-09-15       Impact factor: 3.857

4.  Endogenous production of tumour necrosis factor is required for manganese superoxide dismutase expression by irradiation in the human monocytic cell line THP-1.

Authors:  M Hachiya; S Shimizu; Y Osawa; M Akashi
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

5.  Influence of ubiquinone on the inhibitory effect of adriamycin on mitochondrial oxidative phosphorylation.

Authors:  H Muhammed; C K Kurup
Journal:  Biochem J       Date:  1984-01-15       Impact factor: 3.857

Review 6.  Redox Paradox: A Novel Approach to Therapeutics-Resistant Cancer.

Authors:  Luksana Chaiswing; William H St Clair; Daret K St Clair
Journal:  Antioxid Redox Signal       Date:  2018-02-21       Impact factor: 8.401

7.  Cardiac systolic dysfunction in doxorubicin-challenged rats is associated with upregulation of MuRF2 and MuRF3 E3 ligases.

Authors:  Marcia Gracindo da Silva; Elisabete Mattos; Juliana Camacho-Pereira; Tatiana Domitrovic; Antonio Galina; Mauro W Costa; Eleonora Kurtenbach
Journal:  Exp Clin Cardiol       Date:  2012-09

8.  Short interfering RNA-mediated silencing of glutaredoxin 2 increases the sensitivity of HeLa cells toward doxorubicin and phenylarsine oxide.

Authors:  Christopher Horst Lillig; Maria Elisabet Lönn; Mari Enoksson; Aristi Potamitou Fernandes; Arne Holmgren
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-24       Impact factor: 11.205

9.  Comparative cytotoxicities of various morpholinyl anthracyclines.

Authors:  D G Streeter; D L Taylor; E M Acton; J H Peters
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

Review 10.  Iron chelators with topoisomerase-inhibitory activity and their anticancer applications.

Authors:  V Ashutosh Rao
Journal:  Antioxid Redox Signal       Date:  2012-10-26       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.